arrow
J

Jozine M. ter Maaten

university medical center groningen
H指数:46
被引数:7,979
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implications of urinary albumin-to-creatinine ratio for subsequent kidney function decline and kidney-related outcomes in patients hospitalized for worsening heart failure: Insights from the JROADHF-NEXT registry

尿白蛋白肌酐比值对因心力衰竭加重住院患者后续肾功能下降及肾脏相关结局的影响:JROADHF-NEXT登记研究的启示

2026-09-300
PRE
Effects of natriuresis-guided diuretic therapy in men and women with acute heart failure: insights from PUSH-AHF

钠排泄指导的利尿剂疗法在急性心力衰竭男性和女性中的效果:PUSH-AHF研究的启示

2026-09-280
OAAI
Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1–7), in Acute Heart Failure: Insights from the PUSH-AHF trial

循环二肽基肽酶3水平,作为血管紧张素-(1–7)的拮抗剂,在急性心力衰竭中的作用:PUSH-AHF试验的见解

2026-09-040
OA
2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC)

2026年ESC心血管疾病与慢性肾脏病管理指南,与欧洲肾脏协会(ERA)合作制定:由欧洲心脏病学会(ESC)心血管疾病与慢性肾脏病管理工作组制定

2026-08-280
OAAI
Contemporary Management of Acute Heart Failure

急性心力衰竭的现代管理

JACC
IF0
2026-05-270
PRE
IL-6 and diuretic response in acute heart failure

IL-6和利尿剂反应在急性心力衰竭中的作用

2026-04-250
OAAI
Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure

利尿抵抗风险与以利钠为指导的利尿剂疗法在急性心力衰竭中的疗效

2026-03-270
OAAI
Current Pharmacological and Non-Pharmacological Decongestion Strategies in Acute Heart Failure - Evidence and Practical Guidance

急性心力衰竭的当前药物和非药物治疗减充血策略——证据与实践指南

2025-12-110
OAAI
Corrigendum to “Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy”, Journal of Cardiac Failure volume 31 (2025) P1578-1581/ PMID: 40414278

勘误:“Individual Natriuretic and Diuretic Response in Acute Heart Failure: Insights from the PUSH-AHF Pharmacologic Substudy”, 《心力衰竭杂志》卷31 (2025) P1578-1581/ PMID: 40414278

2025-12-090
OAAI
Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure

急性心力衰竭患者残留的血管内和组织淤血的临床特征及预后影响

2025-11-010
OAAI
Outpatient loop diuretic use and the effect of natriuresis-guided diuretic therapy: A prespecified sub-analysis of the PUSH-AHF study

门诊患者使用袢利尿剂及钠排泄指导利尿剂治疗的效果:PUSH-AHF研究的事先预设亚组分析

2025-10-290
OAAI
JCF In Case You Missed It! ESC Congress 2025

JCF "你可能错过的内容"!ESC Congress 2025

2025-09-220
PRE
The Challenges of Guiding Decongestion With Paraclinical Parameters

运用亚临床参数指导解堵的挑战

2025-08-290
PRE
Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men Hospitalized for Acute Heart Failure

急性心力衰竭住院患者中女性的临床表现、生物标志物轨迹和结局

2025-08-210
PRE
Kidneys Under Pressure: The Consequence of Heart Failure and Elevated Filling Pressures

肾脏承压:心力衰竭和高充盈压的后果

2025-07-280
PRE
Let the drinks flow in chronic heart failure? Insights from the FRESH-UP study

让饮品在慢性心力衰竭中流动?——来自FRESH-UP研究的见解

2025-07-150
PRE
Identifying congestion phenotypes using unsupervised machine learning in acute heart failure

使用无监督机器学习识别急性心力衰竭中的拥堵表型

2025-07-012
OAAI
Response to ‘Simple jugular venous assessment: a new approach to heart failure’

对“简易颈静脉评估:心力衰竭的一种新方法”的回应

2025-06-240
OA
Insights From Around the World: the 2025 Japanese Heart Failure Guidelines

来自世界各地的见解:2025年日本心力衰竭指南

2025-06-210
OAAI